huntington’s disease
Roche’s Huntington’s disease treatment disappoints in Phase III trial
March 23, 2021Manufacturing and Production Huntington's, Phase III trial, Roche, huntington's disease, tominersen
Roche has discontinued dosing in a Phase III trial of its tominersen treatment for Huntington’s disease, following discouraging initial data.
Blood biomarker found to track development of Huntington’s disease
June 8, 2017Research and Development UCL, huntington's disease
Huntington’s disease (HD) is a rare and incurable hereditary condition of the central nervous system. The condition can cause involuntary …
Wave Life Sciences granted FDA orphan drug designation for Huntington’s disease drug
June 22, 2016Research and Development FDA, drug, huntington's disease, wave life sciences
Wave Life Sciences (NASDAQ: WVE) has announced that it has received orphan drug designation for the US Food and Drug …
